Bid Publish Date
10-Nov-2025, 10:32 am
Bid End Date
25-Nov-2025, 11:00 am
EMD
₹6,990
Location
Progress
RAQuantity
1548403
Category
PANTAPROZOLE 40 MG PLUS DOMPERIDONE 10 MG PAN D
Bid Type
Two Packet Bid
Indian Army invites bids for PANTAPROZOLE 40 MG PLUS DOMPERIDONE 10 MG PAN D, PANTOPRAZOLE 40MG PLUS ITOPRIDE 150MG CAP, PANTOPRAZOLE 40 MG PLUS DOMPERIDONE SR 30 MG CAP, PEGASTA INJ PEGFILGRASTIM 6MG, POLY ETHYLENE GLYCOL 3350 AND ELECTROLYTES FOR ORAL USE PEGLEC POWDER 137. 15, POMALIDOMIDE 1 MG TAB, POMALIDOMIDE 2 MG TAB, RABEPRAZOLE 20 MG TAB, RABEPRAZOLE 20MG PLUS DOMEPERIDON 10MG TAB, RIFAMPICIN 600 MG PLUS TAB INH 300MG TAB in CENTRAL DELHI, DELHI. Quantity: 1548403. Submission Deadline: 25-11-2025 11: 00: 00. Submit your proposal before the deadline.
Tender Category
Goods
Bid To RA
No
Item Category
PANTAPROZOLE 40 MG PLUS DOMPERIDONE 10 MG PAN D , PANTOPRAZOLE 40MG PLUS ITOPRIDE 150MG CAP , PANTOPRAZOLE 40 MG PLUS DOMPERIDONE SR 30 MG CAP , PEGASTA INJ PEGFILGRASTIM 6MG , POLY ETHYLENE GLYCOL 3350 AND ELECTROLYTES FOR ORAL USE PEGLEC POWDER 137.15 , POMALIDOMIDE 1 MG TAB , POMALIDOMIDE 2 MG TAB , RABEPRAZOLE 20 MG TAB , RABEPRAZOLE 20MG PLUS DOMEPERIDON 10MG TAB , RIFAMPICIN 600 MG PLUS TAB INH 300MG TAB
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
PANTAPROZOLE 40 MG PLUS DOMPERIDONE 10 MG PAN D
PANTAPROZOLE 40 MG PLUS DOMPERIDONE 10 MG PAN D
PANTOPRAZOLE 40MG PLUS ITOPRIDE 150MG CAP
PANTOPRAZOLE 40MG PLUS ITOPRIDE 150MG CAP
PANTOPRAZOLE 40 MG PLUS DOMPERIDONE SR 30 MG CAP
PANTOPRAZOLE 40 MG PLUS DOMPERIDONE SR 30 MG CAP
PEGASTA INJ PEGFILGRASTIM 6MG
PEGASTA INJ PEGFILGRASTIM 6MG
POLY ETHYLENE GLYCOL 3350 AND ELECTROLYTES FOR ORAL USE PEGLEC POWDER 137.15
POLY ETHYLENE GLYCOL 3350 AND ELECTROLYTES FOR ORAL USE PEGLEC POWDER 137.16
POMALIDOMIDE 1 MG TAB
POMALIDOMIDE 1 MG TAB
POMALIDOMIDE 2 MG TAB
POMALIDOMIDE 2 MG TAB
RABEPRAZOLE 20 MG TAB
RABEPRAZOLE 20 MG TAB
RABEPRAZOLE 20MG PLUS DOMEPERIDON 10MG TAB
RABEPRAZOLE 20MG PLUS DOMEPERIDON 10MG TAB
RIFAMPICIN 600 MG PLUS TAB INH 300MG TAB
RIFAMPICIN 600 MG PLUS TAB INH 300MG TAB
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | PANTAPROZOLE 40 MG PLUS DOMPERIDONE 10 MG PAN D | PANTAPROZOLE 40 MG PLUS DOMPERIDONE 10 MG PAN D | 630,000 | no | [email protected] | 15 | |
| 2 | PANTOPRAZOLE 40MG PLUS ITOPRIDE 150MG CAP | PANTOPRAZOLE 40MG PLUS ITOPRIDE 150MG CAP | 174,000 | no | [email protected] | 15 | |
| 3 | PANTOPRAZOLE 40 MG PLUS DOMPERIDONE SR 30 MG CAP | PANTOPRAZOLE 40 MG PLUS DOMPERIDONE SR 30 MG CAP | 274,000 | no | [email protected] | 15 | |
| 4 | PEGASTA INJ PEGFILGRASTIM 6MG | PEGASTA INJ PEGFILGRASTIM 6MG | 93 | no | [email protected] | 15 | |
| 5 | POLY ETHYLENE GLYCOL 3350 AND ELECTROLYTES FOR ORAL USE PEGLEC POWDER 137.15 | POLY ETHYLENE GLYCOL 3350 AND ELECTROLYTES FOR ORAL USE PEGLEC POWDER 137.16 | 190 | no | [email protected] | 15 | |
| 6 | POMALIDOMIDE 1 MG TAB | POMALIDOMIDE 1 MG TAB | 2,400 | no | [email protected] | 15 | |
| 7 | POMALIDOMIDE 2 MG TAB | POMALIDOMIDE 2 MG TAB | 2,400 | no | [email protected] | 15 | |
| 8 | RABEPRAZOLE 20 MG TAB | RABEPRAZOLE 20 MG TAB | 270,000 | no | [email protected] | 15 | |
| 9 | RABEPRAZOLE 20MG PLUS DOMEPERIDON 10MG TAB | RABEPRAZOLE 20MG PLUS DOMEPERIDON 10MG TAB | 186,000 | no | [email protected] | 15 | |
| 10 | RIFAMPICIN 600 MG PLUS TAB INH 300MG TAB | RIFAMPICIN 600 MG PLUS TAB INH 300MG TAB | 9,320 | no | [email protected] | 15 |
Start
13-Dec-2025, 3:00 pm
End
15-Dec-2025, 3:00 pm
Duration: 48 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 24-11-2025 17:31:09 | |
| 2 | ********** Under PMA | - | 24-11-2025 12:18:26 | |
| 3 | ********** Under PMA | - | 24-11-2025 21:32:52 | |
| 4 | ********** Under PMA | - | 25-11-2025 10:54:59 | |
| 5 | ********** Under PMA | - | 24-11-2025 18:53:48 | |
| 6 | ********** Under PMA | - | 13-11-2025 19:59:30 | |
| 7 | ********** Under PMA | - | 25-11-2025 02:36:41 | |
| 8 | ********** Under PMA | - | 23-11-2025 19:12:02 | |
| 9 | ********** Under PMA | - | 19-11-2025 13:21:58 | |
| 10 | ********** Under PMA | - | 21-11-2025 12:47:06 | |
| 11 | ********** Under PMA | - | 22-11-2025 13:37:00 | |
| 12 | ********** Under PMA | - | 24-11-2025 13:08:49 | |
| 13 | ********** Under PMA | - | 24-11-2025 17:35:18 | |
| 14 | ********** Under PMA | - | 25-11-2025 10:58:37 | |
| 15 | ********** Under PMA | - | 24-11-2025 21:41:54 | |
| 16 | ********** Under PMA | - | 22-11-2025 17:59:01 | |
| 17 | ********** Under PMA | - | 24-11-2025 11:41:53 | |
| 18 | ********** Under PMA | - | 24-11-2025 18:51:21 | |
| 19 | ********** Under PMA | - | 24-11-2025 11:00:14 | |
| 20 | ********** Under PMA | - | 24-11-2025 13:50:03 | |
| 21 | ********** Under PMA | - | 24-11-2025 16:46:00 | |
| 22 | ********** Under PMA | - | 24-11-2025 16:29:55 | |
| 23 | ********** Under PMA | - | 24-11-2025 11:24:18 | |
| 24 | ********** Under PMA | - | 18-11-2025 19:36:18 | |
| 25 | ********** Under PMA | - | 22-11-2025 15:43:42 | |
| 26 | ********** Under PMA | - | 25-11-2025 10:00:19 | |
| 27 | ********** Under PMA | - | 22-11-2025 16:33:10 | |
| 28 | ********** Under PMA | - | 24-11-2025 18:27:27 | |
| 29 | ********** Under PMA | - | 25-11-2025 10:20:16 | |
| 30 | ********** Under PMA | - | 18-11-2025 18:23:15 | |
| 31 | ********** Under PMA | - | 19-11-2025 11:16:16 | |
| 32 | ********** Under PMA | - | 25-11-2025 10:12:30 | |
| 33 | ********** Under PMA | - | 22-11-2025 19:22:17 | |
| 34 | ********** Under PMA | - | 10-11-2025 17:09:20 | |
| 35 | ********** Under PMA | - | 19-11-2025 17:17:37 | |
| 36 | ********** Under PMA | - | 22-11-2025 16:22:12 | |
| 37 | ********** Under PMA | - | 24-11-2025 10:27:54 | |
| 38 | ********** Under PMA | - | 24-11-2025 15:39:49 |
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS